Blood test may spot sarcoma DNA, no surgery needed

NCT ID NCT06958107

Recruiting now Knowledge-focused Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

First seen Jan 23, 2026 · Last updated May 09, 2026 · Updated 18 times

Summary

This study is testing a blood test called liquid biopsy to see if it can find bits of tumor DNA in people with sarcoma (a type of bone or soft tissue cancer). Researchers will collect blood samples from 300 participants before, during, and after treatment to see how well the test works. The goal is to learn if this simple blood draw can help track the cancer without needing repeated tissue biopsies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Atrium Health Wake Forest Baptist Comprehensive Cancer Center
RECRUITING

Winston-Salem, North Carolina, 27103, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Levine Cancer Institute
RECRUITING

Charlotte, North Carolina, 28204, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

SARCOMA